Newsroom | 65528 results

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma delivers 8% revenue growth at CER in 9M 2025 and updates full-year outlook...

BOSTON--(BUSINESS WIRE)--Sonde Health, a global leader in voice AI-based health technology, announced a collaboration with Qualcomm Technologies, Inc. to enable Sonde’s embedded vocal biomarker platform on devices powered by the Snapdragon® AR1 Gen 1, processor. This collaboration enables smart glasses and AR glasses to deliver ambient, privacy and security-focused wellness monitoring through the analysis of everyday speech—without the need for explicit voice commands or user prompts. Sonde’s t...

ABU DHABI, United Arab Emirates--(BUSINESS WIRE)--10X Health (USA) and REVIV Global (UK) today announced a strategic partnership with M42, a global health leader powered by technology, artificial intelligence and genomics, headquartered in Abu Dhabi, to launch 10XREVIV — a groundbreaking collaboration that brings a one-of-a-kind Precision Nutrition System to the Middle East. 10XREVIV represents a new frontier in personalized health optimization, integrating genetic science, blood biomarker anal...

RALEIGH, N.C.--(BUSINESS WIRE)--Merz Aesthetics, la più grande azienda di medicina estetica al mondo, oggi ha annunciato la prossima disponibilità di Ultherapy PRIME per migliorare l'aspetto della lassità cutanea sulle parti anteriori e posteriori delle braccia e sull'addome. Ultherapy PRIME è l'unica soluzione dotata di visualizzazione in tempo reale integrata per il trattamento della parte superiore e inferiore del viso, del collo, del décolleté e oggi anche del corpo*. Il testo originale del...

RALEIGH, N.C.--(BUSINESS WIRE)--Merz Aesthetics, 's werelds grootste bedrijf gespecialiseerd in medische esthetiek, heeft vandaag de aanstaande beschikbaarheid aangekondigd van Ultherapy PRIME om de zichtbaarheid van huidverslapping op de voor- en achterkant van de armen en de buik te verbeteren. Ultherapy PRIME is de enige oplossing met geïntegreerde realtime visualisatie voor de behandeling van het bovengezicht, ondergezicht, de hals, het decolleté en nu ook het lichaam*. Deze bekendmaking is...

HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and nine months ended September 30, 2025. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles (“GAAP”) measure, was $23.9 million for the three months ended September 30, 2025 (“2025 Third Quarter”), an in...

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Citi’s 2025 Global Healthcare Conference on Wednesday, December 3rd, 2025. Management will participate in a Fireside Chat at 11:15 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available a...

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended Sept. 30, 2025. “Our third quarter results reflect strong execution on our core strategic priorities, with year-over-year growth in revenue, census and Adjusted EBITDA,” said Barb Jacobsmeyer, president and CEO of Enhabit. “This progress allowed us to further reduce our bank debt and strengthen the balance sheet during the qua...

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2026 second quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, November 5 at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and...

IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners’ patients, today announced financial results for the third quarter ended September 30, 2025. “When we undertook our organizational restructuring in May, we identified three strategic priorities: accelerate growth from new providers, maximize value from our top-tier clinics, and improve our financial performance through gre...